Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer
Most patients with ovarian cancer (OvCA) present peritoneal disseminated disease at the time of diagnosis. During peritoneal metastasis, cancer cells detach from the primary tumor and disseminate through the intraperitoneal fluid. The peritoneal mesothelial cell (PMC) monolayer that lines the abdomi...
Gespeichert in:
Veröffentlicht in: | International journal of molecular sciences 2021-10, Vol.22 (21), p.11496 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 21 |
container_start_page | 11496 |
container_title | International journal of molecular sciences |
container_volume | 22 |
creator | Pascual-Antón, Lucía Cardeñes, Beatriz Sainz de la Cuesta, Ricardo González-Cortijo, Lucía López-Cabrera, Manuel Cabañas, Carlos Sandoval, Pilar |
description | Most patients with ovarian cancer (OvCA) present peritoneal disseminated disease at the time of diagnosis. During peritoneal metastasis, cancer cells detach from the primary tumor and disseminate through the intraperitoneal fluid. The peritoneal mesothelial cell (PMC) monolayer that lines the abdominal cavity is the first barrier encountered by OvCA cells. Subsequent progression of tumors through the peritoneum leads to the accumulation into the peritoneal stroma of a sizeable population of carcinoma-associated fibroblasts (CAFs), which is mainly originated from a mesothelial-to-mesenchymal transition (MMT) process. A common characteristic of OvCA patients is the intraperitoneal accumulation of ascitic fluid, which is composed of cytokines, chemokines, growth factors, miRNAs, and proteins contained in exosomes, as well as tumor and mesothelial suspended cells, among other components that vary in proportion between patients. Exosomes are small extracellular vesicles that have been shown to mediate peritoneal metastasis by educating a pre-metastatic niche, promoting the accumulation of CAFs via MMT, and inducing tumor growth and chemoresistance. This review summarizes and discusses the pivotal role of exosomes and MMT as mediators of OvCA peritoneal colonization and as emerging diagnostic and therapeutic targets. |
doi_str_mv | 10.3390/ijms222111496 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8584135</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2596037912</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-d58e8e5e729fbc284f9dfd3ec8b875770ff4ac23c24589248db0e5f0653bfb423</originalsourceid><addsrcrecordid>eNpdkctLxDAQxoMoPlaPXqXgxUs1zza9CLL4AmU96FFCmk7cLG2iSVf0vzeLD1QYyAz58fHNfAjtE3zMWINP3GJIlFJCCG-qNbRNOKUlxlW9_qvfQjspLTCmjIpmE20xXleyodU2eryFFMY59E735RjKPII38_dB98V91D650QVfaN8V528hhQFS4XxxB9GNwUOmbmHUKZdLRbDF7FVHp30x1d5A3EUbVvcJ9r7eCXq4OL-fXpU3s8vr6dlNaTgRY9kJCRIE1LSxraGS26azHQMjW1mLusbWcm0oM5SLbJvLrsUgLK4Ea23LKZug00_d52U7QGfAj1H36jm6Qcd3FbRTf3-8m6un8KqkkJwwkQWOvgRieFlCGtXgkoG-1x7CMql8tprLKh88o4f_0EVYRp_XW1EVZnVDVo7KT8rEkFIE-2OGYLUKTv0JLvMHvzf4ob-TYh_8qpYQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2596037912</pqid></control><display><type>article</type><title>Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Pascual-Antón, Lucía ; Cardeñes, Beatriz ; Sainz de la Cuesta, Ricardo ; González-Cortijo, Lucía ; López-Cabrera, Manuel ; Cabañas, Carlos ; Sandoval, Pilar</creator><creatorcontrib>Pascual-Antón, Lucía ; Cardeñes, Beatriz ; Sainz de la Cuesta, Ricardo ; González-Cortijo, Lucía ; López-Cabrera, Manuel ; Cabañas, Carlos ; Sandoval, Pilar</creatorcontrib><description>Most patients with ovarian cancer (OvCA) present peritoneal disseminated disease at the time of diagnosis. During peritoneal metastasis, cancer cells detach from the primary tumor and disseminate through the intraperitoneal fluid. The peritoneal mesothelial cell (PMC) monolayer that lines the abdominal cavity is the first barrier encountered by OvCA cells. Subsequent progression of tumors through the peritoneum leads to the accumulation into the peritoneal stroma of a sizeable population of carcinoma-associated fibroblasts (CAFs), which is mainly originated from a mesothelial-to-mesenchymal transition (MMT) process. A common characteristic of OvCA patients is the intraperitoneal accumulation of ascitic fluid, which is composed of cytokines, chemokines, growth factors, miRNAs, and proteins contained in exosomes, as well as tumor and mesothelial suspended cells, among other components that vary in proportion between patients. Exosomes are small extracellular vesicles that have been shown to mediate peritoneal metastasis by educating a pre-metastatic niche, promoting the accumulation of CAFs via MMT, and inducing tumor growth and chemoresistance. This review summarizes and discusses the pivotal role of exosomes and MMT as mediators of OvCA peritoneal colonization and as emerging diagnostic and therapeutic targets.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms222111496</identifier><identifier>PMID: 34768926</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Abdomen ; Accumulation ; Ascites ; Ascitic fluid ; Ascitic Fluid - chemistry ; Ascitic Fluid - cytology ; Biosynthesis ; Carcinoma, Ovarian Epithelial - pathology ; Cell Line, Tumor ; Chemokines ; Chemoresistance ; Cytokines ; Cytokines - analysis ; Epithelial-Mesenchymal Transition - physiology ; Epithelium - pathology ; Exosomes ; Exosomes - metabolism ; Extracellular vesicles ; Female ; Fibroblasts ; Growth factors ; Humans ; Intercellular Signaling Peptides and Proteins - analysis ; Kinases ; Lipids ; Medical prognosis ; Mesenchyme ; Metastases ; Metastasis ; Mitochondrial DNA ; Ovarian cancer ; Ovarian Neoplasms - pathology ; Peritoneal Neoplasms - secondary ; Peritoneum ; Peritoneum - pathology ; Plasma ; Proteins ; Review ; Stroma ; Tumors</subject><ispartof>International journal of molecular sciences, 2021-10, Vol.22 (21), p.11496</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-d58e8e5e729fbc284f9dfd3ec8b875770ff4ac23c24589248db0e5f0653bfb423</citedby><cites>FETCH-LOGICAL-c415t-d58e8e5e729fbc284f9dfd3ec8b875770ff4ac23c24589248db0e5f0653bfb423</cites><orcidid>0000-0002-8767-060X ; 0000-0002-0976-9719 ; 0000-0002-7270-1629</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584135/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584135/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34768926$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pascual-Antón, Lucía</creatorcontrib><creatorcontrib>Cardeñes, Beatriz</creatorcontrib><creatorcontrib>Sainz de la Cuesta, Ricardo</creatorcontrib><creatorcontrib>González-Cortijo, Lucía</creatorcontrib><creatorcontrib>López-Cabrera, Manuel</creatorcontrib><creatorcontrib>Cabañas, Carlos</creatorcontrib><creatorcontrib>Sandoval, Pilar</creatorcontrib><title>Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Most patients with ovarian cancer (OvCA) present peritoneal disseminated disease at the time of diagnosis. During peritoneal metastasis, cancer cells detach from the primary tumor and disseminate through the intraperitoneal fluid. The peritoneal mesothelial cell (PMC) monolayer that lines the abdominal cavity is the first barrier encountered by OvCA cells. Subsequent progression of tumors through the peritoneum leads to the accumulation into the peritoneal stroma of a sizeable population of carcinoma-associated fibroblasts (CAFs), which is mainly originated from a mesothelial-to-mesenchymal transition (MMT) process. A common characteristic of OvCA patients is the intraperitoneal accumulation of ascitic fluid, which is composed of cytokines, chemokines, growth factors, miRNAs, and proteins contained in exosomes, as well as tumor and mesothelial suspended cells, among other components that vary in proportion between patients. Exosomes are small extracellular vesicles that have been shown to mediate peritoneal metastasis by educating a pre-metastatic niche, promoting the accumulation of CAFs via MMT, and inducing tumor growth and chemoresistance. This review summarizes and discusses the pivotal role of exosomes and MMT as mediators of OvCA peritoneal colonization and as emerging diagnostic and therapeutic targets.</description><subject>Abdomen</subject><subject>Accumulation</subject><subject>Ascites</subject><subject>Ascitic fluid</subject><subject>Ascitic Fluid - chemistry</subject><subject>Ascitic Fluid - cytology</subject><subject>Biosynthesis</subject><subject>Carcinoma, Ovarian Epithelial - pathology</subject><subject>Cell Line, Tumor</subject><subject>Chemokines</subject><subject>Chemoresistance</subject><subject>Cytokines</subject><subject>Cytokines - analysis</subject><subject>Epithelial-Mesenchymal Transition - physiology</subject><subject>Epithelium - pathology</subject><subject>Exosomes</subject><subject>Exosomes - metabolism</subject><subject>Extracellular vesicles</subject><subject>Female</subject><subject>Fibroblasts</subject><subject>Growth factors</subject><subject>Humans</subject><subject>Intercellular Signaling Peptides and Proteins - analysis</subject><subject>Kinases</subject><subject>Lipids</subject><subject>Medical prognosis</subject><subject>Mesenchyme</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Mitochondrial DNA</subject><subject>Ovarian cancer</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Peritoneal Neoplasms - secondary</subject><subject>Peritoneum</subject><subject>Peritoneum - pathology</subject><subject>Plasma</subject><subject>Proteins</subject><subject>Review</subject><subject>Stroma</subject><subject>Tumors</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkctLxDAQxoMoPlaPXqXgxUs1zza9CLL4AmU96FFCmk7cLG2iSVf0vzeLD1QYyAz58fHNfAjtE3zMWINP3GJIlFJCCG-qNbRNOKUlxlW9_qvfQjspLTCmjIpmE20xXleyodU2eryFFMY59E735RjKPII38_dB98V91D650QVfaN8V528hhQFS4XxxB9GNwUOmbmHUKZdLRbDF7FVHp30x1d5A3EUbVvcJ9r7eCXq4OL-fXpU3s8vr6dlNaTgRY9kJCRIE1LSxraGS26azHQMjW1mLusbWcm0oM5SLbJvLrsUgLK4Ea23LKZug00_d52U7QGfAj1H36jm6Qcd3FbRTf3-8m6un8KqkkJwwkQWOvgRieFlCGtXgkoG-1x7CMql8tprLKh88o4f_0EVYRp_XW1EVZnVDVo7KT8rEkFIE-2OGYLUKTv0JLvMHvzf4ob-TYh_8qpYQ</recordid><startdate>20211025</startdate><enddate>20211025</enddate><creator>Pascual-Antón, Lucía</creator><creator>Cardeñes, Beatriz</creator><creator>Sainz de la Cuesta, Ricardo</creator><creator>González-Cortijo, Lucía</creator><creator>López-Cabrera, Manuel</creator><creator>Cabañas, Carlos</creator><creator>Sandoval, Pilar</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8767-060X</orcidid><orcidid>https://orcid.org/0000-0002-0976-9719</orcidid><orcidid>https://orcid.org/0000-0002-7270-1629</orcidid></search><sort><creationdate>20211025</creationdate><title>Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer</title><author>Pascual-Antón, Lucía ; Cardeñes, Beatriz ; Sainz de la Cuesta, Ricardo ; González-Cortijo, Lucía ; López-Cabrera, Manuel ; Cabañas, Carlos ; Sandoval, Pilar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-d58e8e5e729fbc284f9dfd3ec8b875770ff4ac23c24589248db0e5f0653bfb423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Abdomen</topic><topic>Accumulation</topic><topic>Ascites</topic><topic>Ascitic fluid</topic><topic>Ascitic Fluid - chemistry</topic><topic>Ascitic Fluid - cytology</topic><topic>Biosynthesis</topic><topic>Carcinoma, Ovarian Epithelial - pathology</topic><topic>Cell Line, Tumor</topic><topic>Chemokines</topic><topic>Chemoresistance</topic><topic>Cytokines</topic><topic>Cytokines - analysis</topic><topic>Epithelial-Mesenchymal Transition - physiology</topic><topic>Epithelium - pathology</topic><topic>Exosomes</topic><topic>Exosomes - metabolism</topic><topic>Extracellular vesicles</topic><topic>Female</topic><topic>Fibroblasts</topic><topic>Growth factors</topic><topic>Humans</topic><topic>Intercellular Signaling Peptides and Proteins - analysis</topic><topic>Kinases</topic><topic>Lipids</topic><topic>Medical prognosis</topic><topic>Mesenchyme</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Mitochondrial DNA</topic><topic>Ovarian cancer</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Peritoneal Neoplasms - secondary</topic><topic>Peritoneum</topic><topic>Peritoneum - pathology</topic><topic>Plasma</topic><topic>Proteins</topic><topic>Review</topic><topic>Stroma</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pascual-Antón, Lucía</creatorcontrib><creatorcontrib>Cardeñes, Beatriz</creatorcontrib><creatorcontrib>Sainz de la Cuesta, Ricardo</creatorcontrib><creatorcontrib>González-Cortijo, Lucía</creatorcontrib><creatorcontrib>López-Cabrera, Manuel</creatorcontrib><creatorcontrib>Cabañas, Carlos</creatorcontrib><creatorcontrib>Sandoval, Pilar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pascual-Antón, Lucía</au><au>Cardeñes, Beatriz</au><au>Sainz de la Cuesta, Ricardo</au><au>González-Cortijo, Lucía</au><au>López-Cabrera, Manuel</au><au>Cabañas, Carlos</au><au>Sandoval, Pilar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2021-10-25</date><risdate>2021</risdate><volume>22</volume><issue>21</issue><spage>11496</spage><pages>11496-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Most patients with ovarian cancer (OvCA) present peritoneal disseminated disease at the time of diagnosis. During peritoneal metastasis, cancer cells detach from the primary tumor and disseminate through the intraperitoneal fluid. The peritoneal mesothelial cell (PMC) monolayer that lines the abdominal cavity is the first barrier encountered by OvCA cells. Subsequent progression of tumors through the peritoneum leads to the accumulation into the peritoneal stroma of a sizeable population of carcinoma-associated fibroblasts (CAFs), which is mainly originated from a mesothelial-to-mesenchymal transition (MMT) process. A common characteristic of OvCA patients is the intraperitoneal accumulation of ascitic fluid, which is composed of cytokines, chemokines, growth factors, miRNAs, and proteins contained in exosomes, as well as tumor and mesothelial suspended cells, among other components that vary in proportion between patients. Exosomes are small extracellular vesicles that have been shown to mediate peritoneal metastasis by educating a pre-metastatic niche, promoting the accumulation of CAFs via MMT, and inducing tumor growth and chemoresistance. This review summarizes and discusses the pivotal role of exosomes and MMT as mediators of OvCA peritoneal colonization and as emerging diagnostic and therapeutic targets.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>34768926</pmid><doi>10.3390/ijms222111496</doi><orcidid>https://orcid.org/0000-0002-8767-060X</orcidid><orcidid>https://orcid.org/0000-0002-0976-9719</orcidid><orcidid>https://orcid.org/0000-0002-7270-1629</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2021-10, Vol.22 (21), p.11496 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8584135 |
source | MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; PubMed Central; EZB Electronic Journals Library |
subjects | Abdomen Accumulation Ascites Ascitic fluid Ascitic Fluid - chemistry Ascitic Fluid - cytology Biosynthesis Carcinoma, Ovarian Epithelial - pathology Cell Line, Tumor Chemokines Chemoresistance Cytokines Cytokines - analysis Epithelial-Mesenchymal Transition - physiology Epithelium - pathology Exosomes Exosomes - metabolism Extracellular vesicles Female Fibroblasts Growth factors Humans Intercellular Signaling Peptides and Proteins - analysis Kinases Lipids Medical prognosis Mesenchyme Metastases Metastasis Mitochondrial DNA Ovarian cancer Ovarian Neoplasms - pathology Peritoneal Neoplasms - secondary Peritoneum Peritoneum - pathology Plasma Proteins Review Stroma Tumors |
title | Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T16%3A24%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mesothelial-to-Mesenchymal%20Transition%20and%20Exosomes%20in%20Peritoneal%20Metastasis%20of%20Ovarian%20Cancer&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Pascual-Ant%C3%B3n,%20Luc%C3%ADa&rft.date=2021-10-25&rft.volume=22&rft.issue=21&rft.spage=11496&rft.pages=11496-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms222111496&rft_dat=%3Cproquest_pubme%3E2596037912%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2596037912&rft_id=info:pmid/34768926&rfr_iscdi=true |